Total Payments
$318.56
2024 Payments
$14.36
Companies
7
Transactions
20
Medicare Patients
23,476
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$313.18 (98.3%)
Education$5.38 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $313.18 | 18 | 98.3% |
| Education | $5.38 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $121.01 | 6 | $0 (2018) |
| Radius Health, Inc. | $80.92 | 5 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $42.30 | 4 | $0 (2017) |
| GlaxoSmithKline, LLC. | $29.66 | 2 | $0 (2023) |
| Prometheus Laboratories Inc. | $16.83 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $14.36 | 1 | $0 (2024) |
| Sanofi Pasteur Inc. | $13.48 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.36 | 1 | Novartis Pharmaceuticals Corporation ($14.36) |
| 2023 | $18.16 | 1 | GlaxoSmithKline, LLC. ($18.16) |
| 2018 | $141.90 | 9 | Radius Health, Inc. ($80.92) |
| 2017 | $144.14 | 9 | Amgen Inc. ($85.01) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Endocrinology | ||||||
| 10/18/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Endocrinology | ||||||
| 05/16/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Endocrinology | ||||||
| 04/11/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: VACCINES | ||||||
| 03/08/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), ADACEL, NO PRODUCT DISCUSSED | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: VACCINES | ||||||
| 03/01/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Endocrinology | ||||||
| 01/24/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiology | ||||||
| 01/04/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Endocrinology | ||||||
| 01/04/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Endocrinology | ||||||
| 12/06/2017 | Prometheus Laboratories Inc. | — | Food and Beverage | In-kind items and services | $16.83 | General |
| 11/06/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Endocrinology | ||||||
| 08/24/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Endocrinology | ||||||
| 08/08/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: RESPIRATORY | ||||||
| 07/07/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Endocrinology | ||||||
| 04/17/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,424 | 4,071 | $452,451 | $117,258 |
| 2022 | 62 | 9,423 | 14,599 | $1.6M | $358,496 |
| 2021 | 49 | 5,053 | 10,184 | $1.1M | $244,256 |
| 2020 | 63 | 6,576 | 11,937 | $1.4M | $280,058 |
Total Patients
23,476
Total Services
40,791
Medicare Billing
$1.0M
Procedure Codes
201
All Medicare Procedures & Services
201 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 281 | $59,853 | $20,695 | 34.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 96 | 438 | $45,990 | $18,995 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 79 | 122 | $36,722 | $13,801 | 37.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 72 | 72 | $15,696 | $8,830 | 56.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 73 | 74 | $10,508 | $5,785 | 55.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 226 | 336 | $49,728 | $5,531 | 11.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 30 | 148 | $12,136 | $5,004 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 78 | $11,778 | $4,907 | 41.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 247 | 359 | $49,901 | $4,710 | 9.4% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 17 | 19 | $4,921 | $4,598 | 93.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 29 | 133 | $11,438 | $4,323 | 37.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 277 | 397 | $40,494 | $4,109 | 10.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 284 | 445 | $28,925 | $3,386 | 11.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 186 | 287 | $29,274 | $2,537 | 8.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 149 | 206 | $18,952 | $1,961 | 10.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 75 | 75 | $2,325 | $1,292 | 55.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 74 | 74 | $2,220 | $1,274 | 57.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 17 | 19 | $3,040 | $1,157 | 38.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 28 | $2,212 | $966.06 | 43.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 92 | $2,208 | $880.73 | 39.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 150 | 263 | $7,364 | $817.93 | 11.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 23 | 23 | $1,012 | $570.17 | 56.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 24 | 24 | $1,608 | $454.08 | 28.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 22 | 24 | $1,776 | $198.96 | 11.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $715.00 | $190.68 | 26.7% |
About Dr. Karen Maluf, MD
Dr. Karen Maluf, MD is a Internal Medicine healthcare provider based in Chickasha, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689658601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karen Maluf, MD has received a total of $318.56 in payments from pharmaceutical and medical device companies, with $14.36 received in 2024. These payments were reported across 20 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($313.18).
As a Medicare-enrolled provider, Maluf has provided services to 23,476 Medicare beneficiaries, totaling 40,791 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 201 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Chickasha, OK
- Active Since 12/02/2005
- Last Updated 06/28/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689658601
Products in Payments
- Prolia (Biological) $105.44
- Tymlos (Biological) $80.92
- UTIBRON (Drug) $42.30
- TRELEGY ELLIPTA (Drug) $18.16
- Repatha (Biological) $15.57
- LEQVIO (Drug) $14.36
- FLUZONE HIGH-DOSE (Drug) $13.48
- SHINGRIX (Biological) $11.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chickasha
Miguel Rodriguez, M.d, M.D
Internal Medicine — Payments: $215.96
Internal Medicine $215.96
Ross Fisher, Md, MD
Internal Medicine — Payments: $31.70
Internal Medicine $31.70
Anupama Bekkem, M.d, M.D
Internal Medicine — Payments: $28.29
Internal Medicine $28.29
Dr. Thomas Essex, D.o, D.O
Internal Medicine — Payments: $12.59
Internal Medicine $12.59
Mr. John Vallandigham, M.d, M.D
Internal Medicine
Internal Medicine